Anderson James M.

DirectorMERIDIAN BIOSCIENCE INC (VIVO) · full profile →Form 4 · filed Jan 31, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
11
2 non-derivative · 9 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 31, 2023Disposed to issuer(D)28K0
Jan 31, 2023Disposed to issuer(D)5K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 31, 2023Disposed to issuer(D)9K$8.17$69K0
Jan 31, 2023Disposed to issuer(D)9K$16.660
Jan 31, 2023Disposed to issuer(D)17K$23.540
Jan 31, 2023Disposed to issuer(D)12K$21.200
Jan 31, 2023Disposed to issuer(D)6K$12.640
Jan 31, 2023Disposed to issuer(D)6K$13.250
Jan 31, 2023Disposed to issuer(D)12K$17.800
Jan 31, 2023Disposed to issuer(D)9K$17.030
Jan 31, 2023Disposed to issuer(D)9K$15.360

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001567619-23-001531) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about VIVO insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001567619-23-001531"
Ask your agent
Use Arkolith to summarize insider buying and selling at MERIDIAN BIOSCIENCE INC
over the last 90 days and cite the filings.